title: Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
authors.affiliation: Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
authors.forename: Peter H
authors.initials: PH
authors.lastname: O'Donnell
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Artz
authors.forename: Samir D
authors.initials: SD
authors.lastname: Undevia
authors.forename: Rish K
authors.initials: RK
authors.lastname: Pai
authors.forename: Paula
authors.initials: P
authors.lastname: Del Cerro
authors.forename: Sarah
authors.initials: S
authors.lastname: Horowitz
authors.forename: Lucy A
authors.initials: LA
authors.lastname: Godley
authors.forename: John
authors.initials: J
authors.lastname: Hart
authors.forename: Federico
authors.initials: F
authors.lastname: Innocenti
authors.forename: Richard A
authors.initials: RA
authors.lastname: Larson
authors.forename: Olatoyosi M
authors.initials: OM
authors.lastname: Odenike
authors.forename: Wendy
authors.initials: W
authors.lastname: Stock
authors.forename: Koen
authors.initials: K
authors.lastname: Van Besien